Alterity Therapeutics (PRNAD) Assets Average (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Assets Average for 15 consecutive years, with $33.4 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Assets Average rose 241.65% year-over-year to $33.4 million; the TTM figure through Dec 2025 stood at $33.4 million (up 241.65% YoY), while the FY2023 annual figure was $24.1 million, down 12.39% from the prior year.
• Assets Average came in at $33.4 million for Q4 2025 at Alterity Therapeutics, up from $18.2 million in the prior quarter.
• The five-year high for Assets Average was $33.4 million in Q4 2025, with the low at $7.4 million in Q4 2023.
• Average Assets Average over 5 years is $20.6 million, with a median of $22.0 million recorded in 2022.
• Across the five-year window, Assets Average plunged 71.45% in 2023 and jumped 241.65% in 2025, its largest moves.
• Year by year, Assets Average stood at $29.3 million in 2021, then decreased by 12.01% to $25.8 million in 2022, then sank by 71.45% to $7.4 million in 2023, then jumped by 32.92% to $9.8 million in 2024, then surged by 241.65% to $33.4 million in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $33.4 million, $18.2 million, and $9.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.